Expression of herpes simplex virus thymidine kinase in toxoplasma gondii attenuates tachyzoite virulence in mice?

Infection and Immunity

Volumn 67, Issue 10, 1999, Pages 5292-5297

  Radke, Jay R ^a   White, Michael W ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HYBRID PROTEIN; THYMIDINE KINASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CELL CULTURE; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX VIRUS; MOUSE; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOXOPLASMA GONDII;

EID: 0032880316     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.10.5292-5297.1999     Document Type: Article

References (41)

1. Abrahamsen, M. S., T. G. Clark, P. Mascolo, C. A. Speer, and M. W. White. 1993. Developmental gene expression in Eimeria bovis. Mol. Biochem. Parasitol. 57:1-14.
2. Adams, R. L, P. 1969. The effect of endogenous pools of thymidilate on the apparent rate of DNA synthesis. Exp. Cell. Res. 56:55-58.
3. Araujo, F. G., S. M. Williams, F. C. Grumet, and J. S. Remington. 1976. Strain-dependent differences in murine susceptibility to Toxoplasma. Infect. Immun. 13:1528-1530.
4. Bjursell, G., and P. Reichard. 1973. Effects of thymidine on deoxyribonucleoside triphosphate pools and deoxyribonucleic acid synthesis in Chinese hamster ovary cells. J. Biol. Chem. 24:3904-3909.
5. Bohne, W., J. Heesemann, and U. Gross. 1994. Reduced replication of Taxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect. Immun. 62:1761-1767.
6. Bulow, R., and J. Boothroyd. 1991. Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. J. Immunol. 147:3496-3500.
7. Buxton, D., K. Thomson, S. Maley, S. Wright, and H. J. Bos. 1991. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Vet. Rec. 129:89-93.
8. Buxton, D., K. M. Thomson, S. Maley, S. Wright, and H. J. Bos. 1993. Experimental challenge of sheep 18 months after vaccination with a live (S48) Toxoplasma gondii vaccine. Vet. Rec. 133:310-312.
9. Choromanski, L., A. Freyre, R. Popiel, K. Brown, R. Grieve, and G. Shibley. 1995. Safety and efficacy of modified live feline Toxoplasma gondii vaccine. Non-target effects of live vaccines. Dev. Biol. Stand. 84:269-281.
10. Dalton, D. K., S. Pitts-Meek, S. Kesha, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-1742.
11. Donald, R. G. K., and D. S. Roos. 1998. Gene knock-outs and allelic replacements in Toxoplasma gondii: HXGPRT as a selectable marker for hit-and-run mutagenesis. Mol. Biochem. Parasitol. 91:295-305.
12. Dubey, J. P. 1988. Long-term persistence of Toxoplasma gondii in tissues of pigs inoculated with T. gondii oocysts and effect of freezing on viability of tissue cysts in pork. Am. J. Vet. Res. 49:910-913.
13. Dubey, J. P., J. F. Urban, and S. W. Davis. 1991. Protective immunity to toxoplasmosis in pigs vaccinated with a nonpersistent strain of Toxoplasma gondii. Am. J. Vet. Res. 52:1316-1319.
14. Dubey, J. P. 1994. Evaluation of the safety and efficacy of vaccination of nursing pigs with living tachyzoites of two strains of Toxoplasma gondii. J. Parasitol. 80:438-448.
15. Dubey, J. P., D. G. Baker, S. W. Davis, J. F. Urban, and S. K. Shen. 1994. Persistence of immunity to toxoplasmosis in pigs vaccinated with a nonpersistent strain of Toxoplasma gondii. Am. J. Vet. Res. 55:982-987.
16. Eriksson, S., S. Skog, B. Tribukait, and K. Jaderberg. 1984. Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Exp. Cell Res. 155:129-140.
17. Frenkel, J. K., E. R. Pfefferkorn, M. S. Smith, and J. L. Fishback. 1991. Prospective vaccine prepared from a new mutant of Toxoplasma gondii for use in cats. Am. J. Vet. Res. 52:759.
18. Freyre, A., L. Choromanski, J. L. Fishback, and I. Popiel. 1993. Immunization of cats with tissue cysts, bradyzoites, and tachyzoites of the T-263 strain of Toxoplasma gondii. J. Parasitol. 79:716-719.
19. Hill, D. L., P. E. Noker, G. F. Duncan, and S. M. El Dareer. 1980. Disposition of thymidine administered as large doses to rats and mice. Can. Treat. Rep. 65:495-499.
20. Howe, D. K., B. C. Summers, and L. D. Sibley. 1996. Acute virulence in mice is associated with markers on chromosome VIII in Toxoplasma gondii. Infect. Immun. 64:5193-5198.
21. Jerome, M. E., J. R. Radke, W. Bohn, D. S. Roos, and M. W. White. 1998. Toxoplasma gondii bradyzoites form spontaneously during sporozoite-initiated development. Infect. Immun. 64:4838-4844.
22. Kahn, I. A., and L. H. Kasper. 1991. A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice. J. Immunol. 147:3501-3506.
23. Kaufman, H. E., J. S. Remington, and L. Jacob. 1958. Toxoplasmosis: the nature of virulence. Am. J. Opthalmol. 46:255-261.
24. Kim, K., D. Soldati, and J. C. Boothroyd. 1993. Gene replacement in Toxoplasma gondii with chloramphenicol acetyltransferase as selectable marker. Science 262:911-914.
25. Lee, D. J., W. Prensky, G. Krause, and W. L. Hughes. 1976. Blood thymidine level and iododeoxyuridine incorporation and reutilization in DNA in mice given long-acting thymidine pellets. Can. Res. 36:4577-4583.
26. Lindsay, D. S., B. L. Blagburn, and J. P. Dubey. 1993. Safety and results of challenge of weaned pigs given a temperature-sensitive mutant of Toxo-plasma gondii. J. Parasitol. 79:71-76.
27. Luft, B. J., R. G. Brooks, F. K. Conley, R. E. McCabe, and J. S. Remington. 1984. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA 252:913-917.
28. Luft, B. J., and J. S. Remington. 1988. AIDS commentary: toxoplasmic encephalitis. J. Infect. Dis. 157:1.
29. Luft, B. J., and K. G. Castro. 1992. An overview of the problem of toxoplasmosis and pneumocystosis in AIDS in the USA: implications for future therapeutic trials. Eur. J. Clin. Microbiol. Infect. Dis. 10:178.
30. Mortensen, B. T., N. R. Hartmann, I. J. Christensen, J. K. Larsen, T. Kristensen, S. B. Wieslander, and N. I. Nissen. 1986. Synchronization of the human promyelocytic cell line HL 60 by thymidine. Cell Tissue Kinet. 19: 351-364.
31. Radke, J. R., and M. W. White. 1998. A cell cycle model for the tachyzoite of Toxoplasma gondii using the herpes simplex virus thymidine kinase. Mol. Biochem. Parasitol. 94:237-247.
32. Remington, J. S., and G. Desmonts. 1990. Toxoplasmosis, p. 89-195. In J. S. Remington and J. O. Klein (ed.). Infectious disease of the fetus and newborn infant, 3rd ed. W. B. Saunders Co., Philadelphia, Pa.
33. Roos, D. S., R. G. K. Donald, N. S. Morrissette, and A. L. C. Moulton. 1995. Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii. Methods Cell Biol. 45:25-61.
34. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1982. Molecular cloning: a laboratory manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
35. Striepen, B., C. Y. He, M. Natrajt, D. Soldati, and D. S. Roos. 1998. Expression, selection, and organellar targeting of the green fluorescent protein in Toxoplasma gondii. Mol. Biochem. Parasitol. 92:325-338.
36. Suzuki, Y., M. A. Orellana, S. Y. Wong, F. K. Copnley, and J. S. Remington. 1993. Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice. Infect. Immun. 61: 2284-2288.
37. Villard, O., E. Candolfi, D. J. P. Ferguson, L. Marcellin, and T. Kien. 1997. Loss of oral infectivity of tissue cysts of Toxoplasma gondii RH strain to outbred swiss webster mice. Int. J. Parasitol. 27:1555-1559.
38. Waldeland, H., and J. K. Frenkel. 1983. Live and killed vaccines against toxoplasmosis in mice. J. Parasitol. 69:60.
39. Waslting, J. M., D. Harkins, S. Maley, E. Innes, W. Panton, K. Thomson, and D. Buxton. 1995. Kinetics of the local and systemic antibody response to primary and secondary infection with S48 Toxoplasma gondii in sheep. J. Comp. Pathol. 112:53-62.
40. Wilkins, M. F., E. O'Connel, and W. A. TePunga. 1988. Toxoplasmosis in sheep. III. Further evaluation of the ability of a live Toxoplasma gondii vaccine to prevent lamb losses and reduce congenital infection following experimental oral challenge. N. Z. Vet. J. 36:86-89.
41. Williams, D. M., F. C. Grumet, and J. S. Remington. 1978. Genetic control of murine resistance to Toxoplasma gondii. Infect. Immun. 19:416-420.